Tradestie Institutional Equity Comparison Engine
SENEB vs HLF โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SENEB Overall Edge
SENEB Captures Institutional Edge (2โ2 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to SENEB (SENEB) driven by superior Growth & Margin, Momentum & Technical while HLF counters with relative strength in Valuation, Options & Structure. Fundamentally, SENEB trades at 48.1x Forward P/E with 8.9% operating margin (+7.1% YoY revenue) versus HLF at 5.3x Forward P/E and 9.8% operating margin (+6.0% YoY). In options structure, SENEB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against HLF sits in SURGE (5th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
HLF
SENEB 48.1x vs HLF 5.3x Fwd P/E
Growth & Margin Winner
SENEB
Op Margin 8.9% vs 9.8% ยท YoY +7.1% vs +6.0%
Momentum & Technical Winner
SENEB
1Y +138.9% vs +71.3% ยท 52W Pos 72% vs 64%
Options & Structure Winner
HLF
UNCLASSIFIED (N/A IV) vs SURGE (5th %ile IV)
SENEB
US Equity
SENEB
Institutional Equity
$170.26
-1.47% 1D
Market Cap
$1.2B
1M Return
-9.44%
1Y Return
+138.93%
Forward P/E
48.1x
Unified AI Score
54.4 / 100
HOLD
Tech 50.0
Fund 50.0
Flow 50.0
Mom 50.0
HLF
NYSE
Herbalife Ltd.
Wholesale-Drugs, Proprietaries & Druggists' Sundries
$16.15
+1.19% 1D
Market Cap
$1.7B
1M Return
+10.62%
1Y Return
+71.26%
Forward P/E
5.3x
Unified AI Score
35.4 / 100
SELL
Tech 50.0
Fund 30.0
Flow 59.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SENEB +138.93%
HLF +71.26%
Spread: +25.78 pp (HLF Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
SENEB TTM Op. Margin: 8.9%
HLF TTM Op. Margin: 9.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SENEB vs HLF. Trailing 12-month operating profitability (SENEB 8.9% vs HLF 9.8%) and valuation multiples (SENEB 48.1x vs HLF 5.3x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SENEB | HLF | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.2B | $1.7B | Larger Scale | HLF |
| Trailing P/E Ratio Valuation | 10.0x | 9.4x | Lower Multiple | HLF |
| Forward P/E Ratio Valuation | 48.1x | 5.3x | Lower Multiple | HLF |
| Revenue Growth (YoY) Growth | +7.1% | +6.0% | Higher Growth | SENEB |
| Operating Margin (TTM) Profitability | 8.9% | 9.8% | Higher Margin | HLF |
| Net Profit Margin Profitability | 6.6% | 3.4% | Higher Margin | SENEB |
| Return on Equity (ROE) Capital Efficiency | 16.1% | 0.0% | Higher ROE | SENEB |
| 52-Week Range Position Momentum | 72% ($71โ$209) | 64% ($9โ$20) | Stronger Trend | SENEB |
| Beta / 30D Volatility Risk Regime | 0.10ฮฒ ยท 88% Vol | 1.06ฮฒ ยท 47% Vol | Lower Realized Risk | HLF |
| Unified Institutional Score Composite Signal | 54.4 / 100 (HOLD) | 35.4 / 100 (SELL) | Higher Composite | SENEB |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SENEB vs HLF Buy Guide
SENEB
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
HLF
SURGE
5d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
5th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SENEB nor HLF registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.